Michal Bar-Natan, MD
Icahn School of Medicine at Mount Sinai
1
1
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
John Mascarenhas, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Ronald Hoffman, MD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
Worked with same sponsors:
Ruben Mesa, MD
Mays Cancer Center at UT Health
Shared therapeutic areas:
Worked with same sponsors:
Yang Shen, MD
Ruijin Hospital
Shared therapeutic areas:
David Schiff, MD
ABTC/University of Virginia
Shared therapeutic areas:
Worked with same sponsors:
Ranjit Bindra, MD
ABTC/Yale University
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation
All 1 trials loaded